Skip to main content
. 2014 Aug 15;7(9):6199–6205.

Table 2.

Analysis of factors on cervical lymph node metastases in patients with PTMC (n = 402)

Variable CLNM number (%) Rate of metastasis (%) P value
Gender
    Female 117 of 323 (36.2) 29.1 0.032
    Male 39 of 79 (49.4) 9.7
Age at diagnosis (years)
    < 45 83 of 192 (43.2) 20.6 0.082
    ≥ 45 73 of 210 (34.7) 18.2
Tumour size (mm)
    ≤ 5 mm 67 of 204 (32.8) 16.7 0.013
    > 5 mm 89 of 198 (44.9) 22.1
Location
    Bilateral 46 of 78 (58.8) 11.4 0.000
    Ipsilateral 110 of 324(34.0) 27.4
Tumor number
    Solitary lesion 103 of 305 (33.8) 25.6 0.000a
        Upper third 26 of 110 (23.6) 6.5 0.028b
        Middle third 41 of 101 (40.6) 10.2
        Lower third 35 of 89 (39.3) 8.7
        Isthmus 1 of 5 (20.0) 0.2
    Multifocal lesions 52 of 97 (53.6) 12.9
        Multifocal in both lobes 46 of 78 (59.0) 11.4 0.032c
        Multifocal in affected lobe 6 of 19 (31.6) 1.5
Thyroid capsular invasion
    Yes 57 of 119 (47.9) 14.2 0.015
    No 99 of 283 (35.0) 24.6
Chronic lymphocytic thyroiditis
    Abscent 115 of 315 (36.5) 28.6 0.072
    Present 41 of 87 (47.1) 10.2

PTMC: papillary thyroid microcarcinoma.

a

The P value means the difference between the group solitary lesion and multifocal lesions.

b

The P value means the difference among the upper third, middle third, lower third, and isthmus in the group of solitary lesion.

c

The P value means the difference between the group multifocal in both lobes and in affected lobe in the group of multifocal lesions.